![]() Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases. | Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. | ||
Founding Date | Founding Date 1997 | Founding Date 2011 | Founding Date 2004 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Daix, FR HQ | Locations Garching bei München, DE HQ München, DE |
Employees | Employees 118 | Employees 114 | Employees 5403% increase |
Valuation ($) | Valuation ($) 285.9 m | Valuation ($) 231 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) €4.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr226.6m (FY, 2025) | Gross profit €7.9m (FY, 2025) | Gross profit N/A |
Net income | Net income (kr332.9m) (FY, 2025) | Net income (€354.1m) (FY, 2025) | Net income N/A |

Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
View companyITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment.
View company